Taking a chance on an untested idea can give rise to life-changing cancer treatments. Here are some of the most exciting developments and the new thinking behind them
researched”. Margaret Martin was diagnosed with leiomyosarcoma in 2016, a rare cancer that grows in the hollow organs of the body, including the intestines, stomach, bladder or uterus, in females. One study suggests that it returns in 40 per cent of cases and the chances are highest in the first five years after treatment. Scientists at Dundee University are carrying out the first UK study looking at how DNA damage leads to sarcoma, a group of poorly understood cancers affecting the bones or connective tissues in the body. I feel very blessed to be in this position. Current treatment for many sarcomas is limited and there are few options for patients who don’t respond to first line chemotherapy or present at a more advanced stage.
Dundee University awarded cash boost for research on World Cancer Day
Professor Kevin Hiom.
Thank you for signing up to The Courier daily newsletter
Something went wrong - please try again later. Sign Up
Dundee University is one of 16 institutions from across the globe to benefit from new funding on World Cancer Day.
Worldwide Cancer Research awarded the campus £190,514 towards research into how sarcoma, a rare tissue cancer, develops.
The funding was announced on World Cancer Day, which took place on Thursday, and it is hoped it will help identify new treatments.
Dundee University’s Professor Kevin Hiom and his team are studying how certain genetic mutation in DNA lead to sarcoma.
STEM CAMPAIGN
HOPE IN SIGHT: A team of scientists from Dundee, the University of Texas and the City of Hope Cancer Center in LA will look to build on recent discoveries. AN acclaimed academic from the University of Dundee is set to benefit from a new million-dollar international award to help find more effective treatments with fewer side effects for Ewing’s sarcoma – a rare type of cancer that mainly affects children and young people. Professor Kevin Hiom, from the University’s School of Medicine, will jointly lead a transatlantic team of scientists who were awarded a Paediatric Cancer New Discoveries Challenge award of almost $1million, approximately £770,000.